Author

Bill H. Chang

Oregon Health & Science UniversityORCID 0000-0003-3783-1820Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Jeffrey W. TyneriD· 1 shared Karina Thiel-KlareiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

2 top collaborators · 1 mutual co-author link

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Jeffrey W. TynerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMay 16, 2024

In vivo Targeting MEK and TNK2/SRC pathways in PTPN11 driven leukemia

Bill H. Chang, Karina Thiel-Klare, Jeffrey W. Tyner

This study shows that combining MEK and TNK2/SRC inhibitors effectively treats PTPN11-mutant leukemias in mouse models and patient-derived xenografts.

1 citation

mouseexperimental assay

𝕏 PostBluesky